|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1204141466 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
201107s2020 xx o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d EBLCP
|d REDDC
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|
| 020 |
|
|
|a 9781119585329
|
| 020 |
|
|
|a 1119585325
|
| 035 |
|
|
|a (OCoLC)1204141466
|
| 050 |
|
4 |
|a RS199.5
|b .S586 2021
|
| 082 |
0 |
4 |
|a 615.19
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Shunmugaperumal, Tamilvanan.
|
| 245 |
1 |
0 |
|a Oil-In-Water Nanosized Emulsions for Drug Delivery and Targeting
|h [electronic resource].
|
| 260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2020.
|
| 300 |
|
|
|a 1 online resource (465 p.)
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Cover -- Title Page -- Copyright Page -- Contents -- LIST OF CONTRIBUTORS -- FOREWORD -- PREFACE -- CHAPTER 1 INTRODUCTION: AN OVERVIEW OF NANOSIZED EMULSIONS -- 1.1. INTRODUCTION -- 1.2. CONCLUSION -- REFERENCES -- CHAPTER 2 FORMULATION DEVELOPMENT OF OIL-IN-WATER NANOSIZED EMULSIONS -- 2.1. INTRODUCTION -- 2.2. FDA-APPROVED OILS, EMULSIFIERS, AND AUXILIARY OR MISCELLANEOUS EXCIPIENTS -- 2.3. CURRENT AND NEAR FUTURE DIRECTION -- 2.4. LIPOPHILIC API INCORPORATION PATTERN INTO NANOSIZED EMULSIONS -- 2.5. QbD APPROACH TO OPTIMIZE EMULSION -- 2.6. CONCLUSION -- REFERENCES
|
| 505 |
8 |
|
|a CHAPTER 3 CHARACTERIZATION AND SAFETY ASSESSMENT OF OIL-IN-WATER NANOSIZED EMULSIONS -- 3.1. INTRODUCTION -- 3.2. PHYSICAL AND VISUAL EVALUATIONS -- 3.3. CHEMICAL AND BIOLOGICAL EVALUATIONS -- 3.4. SAFETY AND EFFICACY ASSESSMENTS -- 3.5. CONCLUSION -- REFERENCES -- CHAPTER 4 MANUFACTURING AND POSITIONING (GENERATIONS) OF OIL-IN-WATER NANOSIZED EMULSIONS -- 4.1. INTRODUCTION -- 4.2. GENERATIONS OF O/W NANOSIZED EMULSIONS -- 4.3. PREPARATION METHODS FOR API-FREE/LOADED O/W NANOSIZED EMULSIONS -- 4.4. CONCLUSION -- REFERENCES -- CHAPTER 5 BIOFATE OF NANOSIZED EMULSIONS -- 5.1. INTRODUCTION
|
| 505 |
8 |
|
|a 5.2. BIOFATE OF O/W NANOSIZED EMULSIONS -- 5.3. CLINICAL ISSUES OF FIRST-GENERATION NANOSIZED EMULSIONS -- 5.4. CONCLUSION -- REFERENCES -- CHAPTER 6 MEDICAL OR THERAPEUTICAL APPLICATIONS OF OIL-IN-WATER NANOSIZED EMULSIONS -- 6.1. INTRODUCTION -- 6.2. MEDICAL OR THERAPEUTICAL APPLICATIONS OF O/W NANOSIZED EMULSIONS -- 6.3. CONCLUSION -- REFERENCES -- PART I OVERVIEW OF TOCOL-BASED EMULSIONS, OXYGEN-CARRYING EMULSIONS, EMULSIONS WITH DOUBLE OR TRIPLE CARGOS AND EMULSION-LIKE DISPERSIONS
|
| 505 |
8 |
|
|a CHAPTER 7 OVERVIEW OF TOCOL-BASED EMULSIONS, OXYGEN-CARRYING EMULSIONS, EMULSIONS WITH DOUBLE OR TRIPLE CARGOS AND EMULSION-LIKE DISPERSIONS -- CHAPTER 7.1 TOCOL-BASED NANOSIZED EMULSIONS -- 7.1.1. INTRODUCTION -- 7.1.2. FORMULATION DEVELOPMENT USING TOCOL -- 7.1.3. NON- AND PRE-CLINICAL SAFETY STUDIES -- 7.1.4. THERAPEUTIC APPLICATIONS -- 7.1.5. CONCLUSION -- REFERENCES -- CHAPTER 7.2 OXYGEN-CARRYING EMULSIONS -- 7.2.1. INTRODUCTION -- 7.2.2. RATIONALE FOR SELECTING PERFLUOROCARBON FOR IN VIVO OXYGEN TRANSPORT -- 7.2.3. FORMULATION OF STABLE INJECTABLE PERFLUOROCARBON EMULSIONS
|
| 505 |
8 |
|
|a 7.2.4. MULTIFUNCTIONAL PERFLUOROCARBON-BASED EMULSIONS -- 7.2.5. GENERATIONS AND HURDLES OF PERFLUOROCARBON-BASED NANOSIZED EMULSIONS AS OXYGEN CARRIERS -- 7.2.6. PROPOSED SOLUTIONS TO OVERCOME THE HURDLES OF PERFLUOROCARBON-BASED NANOSIZED EMULSIONS USED AS OXYGEN CARRIERS -- 7.2.7. CONCLUSION -- REFERENCES -- CHAPTER 7.3 NANOSIZED EMULSIONS FOR MULTIPLE MEDICAMENT LOADINGS, IMAGING, AND THERANOSTIC PURPOSES -- 7.3.1. INTRODUCTION -- 7.3.2. BRIEF REVIEW OF RESEARCH REPORTS ON NANOSIZED EMULSIONS FOR IMAGING AND THERANOSTIC PURPOSE
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Drug delivery systems.
|
| 650 |
|
0 |
|a Emulsions.
|
| 650 |
|
0 |
|a Oils and fats
|x Solubility.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|
| 650 |
|
2 |
|a Emulsions
|
| 650 |
|
6 |
|a Systèmes d'administration de médicaments.
|
| 650 |
|
6 |
|a Émulsions.
|
| 650 |
|
6 |
|a Huiles et graisses
|x Solubilité.
|
| 650 |
|
7 |
|a emulsion.
|2 aat
|
| 650 |
|
7 |
|a Drug delivery systems
|2 fast
|
| 650 |
|
7 |
|a Emulsions
|2 fast
|
| 758 |
|
|
|i has work:
|a Oil-in-water nanosized emulsions for drug delivery and targeting (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCG8kdgDKCHg4rWR6Rymtyq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Shunmugaperumal, Tamilvanan
|t Oil-In-Water Nanosized Emulsions for Drug Delivery and Targeting
|d Newark : John Wiley & Sons, Incorporated,c2020
|z 9781119585220
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=6382205
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6382205
|
| 994 |
|
|
|a 92
|b IZTAP
|
